Immunotherapy and Prostate Cancer
November 18, 2024: Immunotherapy for Prostate Cancer: What’s Now, What’s Next
While patients with advanced prostate cancer have many options to help manage the disease, more treatments are urgently needed. Harnessing a patient’s immune system to kill prostate cancer cells is one approach.
Learn about your immune system, the connection to prostate cancer, available treatments, and the future of this exciting field. PCF-funded Young Investigator Nicholas Zorko, MD, PhD of the University of Minnesota hosts a discussion with Neeraj Agarwal, MD, of the Huntsman Cancer Institute, University of Utah, and Sumit K. Subudhi, MD, PhD, of MD Anderson Cancer Center. We’re honored that a patient successfully treated through immunotherapy joins us to share his experiences. Special thanks to Dendreon and Exelixis for their support of this program.